State Street’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26K Hold
15,765
﹤0.01% 4179
2025
Q1
$24.9K Hold
15,765
﹤0.01% 4181
2024
Q4
$52.8K Hold
15,765
﹤0.01% 4102
2024
Q3
$29.6K Hold
15,765
﹤0.01% 4177
2024
Q2
$31.1K Buy
15,765
+4,100
+35% +$8.08K ﹤0.01% 4223
2024
Q1
$35.8K Hold
11,665
﹤0.01% 4210
2023
Q4
$27.2K Hold
11,665
﹤0.01% 4302
2023
Q3
$46.7K Hold
11,665
﹤0.01% 4302
2023
Q2
$47.4K Hold
11,665
﹤0.01% 4431
2023
Q1
$35.9K Sell
11,665
-4
-0% -$12 ﹤0.01% 4583
2022
Q4
$31.5K Hold
11,669
﹤0.01% 4659
2022
Q3
$47K Hold
11,669
﹤0.01% 4670
2022
Q2
$82K Buy
11,669
+344
+3% +$2.42K ﹤0.01% 4598
2022
Q1
$133K Sell
11,325
-18,898
-63% -$222K ﹤0.01% 4537
2021
Q4
$555K Hold
30,223
﹤0.01% 3980
2021
Q3
$756K Buy
30,223
+522
+2% +$13.1K ﹤0.01% 3850
2021
Q2
$1.88M Sell
29,701
-23,588
-44% -$1.49M ﹤0.01% 3560
2021
Q1
$6.57M Buy
53,289
+19,679
+59% +$2.42M ﹤0.01% 2936
2020
Q4
$3.82M Buy
33,610
+6,887
+26% +$783K ﹤0.01% 3097
2020
Q3
$3.19M Buy
26,723
+6,420
+32% +$767K ﹤0.01% 3008
2020
Q2
$2.53M Buy
20,303
+10,821
+114% +$1.35M ﹤0.01% 3085
2020
Q1
$1.83M Buy
9,482
+5,847
+161% +$1.13M ﹤0.01% 3100
2019
Q4
$1.21M Buy
3,635
+294
+9% +$98.2K ﹤0.01% 3370
2019
Q3
$1.08M Buy
3,341
+445
+15% +$144K ﹤0.01% 3379
2019
Q2
$1.25M Buy
2,896
+1,055
+57% +$455K ﹤0.01% 3379
2019
Q1
$1.04M Sell
1,841
-707
-28% -$400K ﹤0.01% 3329
2018
Q4
$756K Buy
2,548
+667
+35% +$198K ﹤0.01% 3380
2018
Q3
$1.34M Buy
1,881
+580
+45% +$412K ﹤0.01% 3357
2018
Q2
$759K Buy
1,301
+80
+7% +$46.7K ﹤0.01% 3431
2018
Q1
$3.31M Buy
+1,221
New +$3.31M ﹤0.01% 2972